Literature DB >> 9430676

NF-kappa B p105 processing via the ubiquitin-proteasome pathway.

C Sears1, J Olesen, D Rubin, D Finley, T Maniatis.   

Abstract

The p50 subunit of NF-kappa B is generated by proteolytic processing of a 105-kDa precursor (p105) in yeast and mammalian cells. Here we show that yeast mutants in the ubiquitin-proteasome pathway inhibit or abolish p105 processing. Specifically, p105 processing is inhibited by a mutation in a 20 S proteasome subunit (pre1-1), by mutations in the ATPases located in the 19 S regulatory complexes of the proteasome (yta1, yta2/sug1, yta5, cim5), and by a mutation in a proteasome-associated isopeptidase (doa4). A ubiquitinated intermediate of the p105 processing reaction accumulates in some of these mutants, strongly suggesting that ubiquitination is required for processing. However, none of the ubiquitin conjugating enzyme mutants tested (ubc1, -2, -3, -4/5, -6/7, -8, -9, -10, -11) had an effect on p105 processing, suggesting that more than one of these enzymes is sufficient for p105 processing. Interestingly, a mutant "N-end rule" ligase does not adversely affect p105 processing, showing that the N-end rule pathway is not involved in degrading the C-terminal region of p105. Unexpectedly, we found that a glycine-rich region of p105 that is required for p105 processing in mammalian cells is not required for processing in yeast. Thus, p105 processing in both yeast and mammalian cells requires the ubiquitin-proteasome pathway, but the mechanisms of processing, while similar, are not identical.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430676     DOI: 10.1074/jbc.273.3.1409

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Modulation of CRX transactivation activity by phosducin isoforms.

Authors:  X Zhu; C M Craft
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 2.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

3.  Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.

Authors:  S Ryu; S Kodama; K Ryu; D A Schoenfeld; D L Faustman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites.

Authors:  Kurt Schaecher; Jean-Michel Goust; Naren L Banik
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

5.  Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome.

Authors:  D M Rubin; M H Glickman; C N Larsen; S Dhruvakumar; D Finley
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

6.  Dependence of proteasome processing rate on substrate unfolding.

Authors:  Allen Henderson; Jenny Erales; Martin A Hoyt; Philip Coffino
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

7.  Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.

Authors:  A Orian; A L Schwartz; A Israël; S Whiteside; C Kahana; A Ciechanover
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

8.  Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC.

Authors:  Kam-Leung Siu; Kit-San Yuen; Carlos Castaño-Rodriguez; Zi-Wei Ye; Man-Lung Yeung; Sin-Yee Fung; Shuofeng Yuan; Chi-Ping Chan; Kwok-Yung Yuen; Luis Enjuanes; Dong-Yan Jin
Journal:  FASEB J       Date:  2019-04-29       Impact factor: 5.191

9.  A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome.

Authors:  Erin K Schrader; Kristine G Harstad; Robert A Holmgren; Andreas Matouschek
Journal:  J Biol Chem       Date:  2011-09-15       Impact factor: 5.157

10.  Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.

Authors:  L Lin; G N DeMartino; W C Greene
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.